We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$92.6M
AUM Growth
+$5.75M
Cap. Flow
+$2.75M
Cap. Flow %
2.97%
Top 10 Hldgs %
32.24%
Holding
102
New
26
Increased
26
Reduced
27
Closed
15

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.58M
2
VTRS icon
Viatris
VTRS
+$3.19M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$2.28M
4
ELV icon
Elevance Health
ELV
+$1.89M
5
MSFT icon
Microsoft
MSFT
+$1.76M

Top Sells

Rank Stock Value
1
SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
+$4.96M
2
NOW icon
ServiceNow
NOW
+$1.78M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.34M
4
CI icon
Cigna
CI
+$1.28M
5
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$1.26M

Sector Composition

Rank Sector Weight
1 Healthcare 56.86%
2 Technology 15.15%
3 Communication Services 6.25%
4 Financials 3.98%
5 Consumer Discretionary 3.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MYOK
51
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$618K 0.67%
12,671
-5,830
-32% -$303K
ONCE
52
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$599K 0.65%
+8,998
New +$520K
DXCM icon
53
DexCom
DXCM
$32B
$588K 0.64%
+31,728
New +$469K
DBX icon
54
Dropbox
DBX
$8.12B
$558K 0.6%
+17,855
New +$539K
TSLA icon
55
Tesla
TSLA
$1.3T
$506K 0.55%
28,530
-3,870
-12% -$85.1K
ICLR icon
56
Icon
ICLR
$12.7B
$481K 0.52%
4,072
-891
-18% -$102K
MMSI icon
57
Merit Medical Systems
MMSI
$5.32B
$462K 0.5%
10,198
-3,948
-28% -$179K
TREE icon
58
LendingTree
TREE
$451M
$443K 0.48%
1,349
-357
-21% -$128K
BSX icon
59
Boston Scientific
BSX
$71.5B
$409K 0.44%
+14,970
New +$407K
NVDA icon
60
NVIDIA
NVDA
$5.42T
$404K 0.44%
69,800
-81,960
-54% -$481K
ELGX
61
DELISTED
Endologix Inc
ELGX
$403K 0.44%
9,532
+368
+4% +$15.8K
ALDR
62
DELISTED
Alder Biopharmaceuticals
ALDR
$378K 0.41%
+29,779
New +$431K
JNCE
63
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$333K 0.36%
14,916
+651
+5% +$14.4K
SNNA
64
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$326K 0.35%
17,343
-283,568
-94% -$4.96M
BLUE
65
DELISTED
bluebird bio
BLUE
$298K 0.32%
135
-17
-11% -$43.2K
SYNH
66
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$271K 0.29%
7,623
+3,235
+74% +$127K
RGNX icon
67
Regenxbio
RGNX
$708M
$264K 0.29%
8,856
+462
+6% +$13.4K
ECYT
68
DELISTED
Endocyte, Inc. Common Stock
ECYT
$256K 0.28%
+28,204
New +$156K
PTLA
69
CALL
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$235K 0.25%
+7,200
New +$316K
ARAY icon
70
Accuray
ARAY
$34M
$231K 0.25%
46,216
+5,620
+14% +$29.5K
KURA icon
71
Kura Oncology
KURA
$850M
$210K 0.23%
11,218
-7,372
-40% -$144K
CUTR
72
DELISTED
Cutera, Inc.
CUTR
$206K 0.22%
4,103
-125
-3% -$6.11K
PAGS icon
73
PagSeguro Digital
PAGS
$2.55B
$195K 0.21%
+5,101
New +$164K
CSII
74
DELISTED
Cardiovascular Systems, Inc.
CSII
$189K 0.2%
8,634
+2,032
+31% +$48.8K
NITE
75
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$149K 0.16%
10,412
+374
+4% +$5.11K
1 2
3
4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q1 2018 Portfolio in Review

As of Q1 2018, Partner Investment Management held 102 positions worth $92.6M, up 6.6% from $86.8M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Partner Investment Management's Q1 2018 filing shows 26 new, 26 increased, 27 reduced and 15 closed positions. Its largest new stake was Bristol-Myers Squibb: 55,719 shares worth $3.52M. The largest sale was Sienna Biopharmaceuticals, Inc., an estimated $4.96M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 49% a quarter earlier, followed by Technology and Communication Services.

  • Partner Investment Management's largest Q1 2018 buy was Bristol-Myers Squibb: 55,719 shares worth $3.52M.
  • Partner Investment Management added most to Elevance Health in Q1 2018, an estimated $1.89M increase.
  • Partner Investment Management's biggest Q1 2018 reduction was Sienna Biopharmaceuticals, Inc., cutting an estimated $4.96M.
  • Partner Investment Management fully exited ServiceNow in Q1 2018, selling an estimated $1.78M.
  • Partner Investment Management's ten largest holdings make up 32% of its $92.6M portfolio in Q1 2018.
  • Partner Investment Management opened 26 new positions and closed 15 in Q1 2018.
  • Partner Investment Management's portfolio value rose 6.6% quarter-over-quarter to $92.6M.

Based on Partner Investment Management's 13F filing for Q1 2018, filed 15 May 2018.